Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical … Read more
Jiangsu Nanfang Medical (603880) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.048x
Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has a cash flow conversion efficiency ratio of 0.048x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.53 Million) by net assets (CN¥259.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jiangsu Nanfang Medical - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Jiangsu Nanfang Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jiangsu Nanfang Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Nanfang Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FAP Agri Tbk PT
JK:FAPA
|
0.182x |
|
West Red Lake Gold Mines Ltd.
OTCGREY:WRLGF
|
0.132x |
|
United Security Bancshares
NASDAQ:UBFO
|
0.050x |
|
Kelly Partners Group Holdings Limited
OTCQX:KPGHF
|
0.052x |
|
China Fangda Group Co Ltd
SHE:200055
|
0.006x |
|
Golden Flower Tbk PT
JK:POLU
|
0.204x |
|
Gaotu Techedu Inc
F:18WA
|
N/A |
|
Sarawak Oil Palms Bhd
KLSE:5126
|
0.021x |
Annual Cash Flow Conversion Efficiency for Jiangsu Nanfang Medical (2012–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥284.41 Million | CN¥63.32 Million | 0.223x | +580.74% |
| 2023-12-31 | CN¥474.22 Million | CN¥15.51 Million | 0.033x | -35.01% |
| 2022-12-31 | CN¥621.48 Million | CN¥31.28 Million | 0.050x | +139.12% |
| 2021-12-31 | CN¥654.90 Million | CN¥-84.25 Million | -0.129x | -158.50% |
| 2020-12-31 | CN¥700.80 Million | CN¥154.12 Million | 0.220x | +278.28% |
| 2019-12-31 | CN¥567.52 Million | CN¥32.99 Million | 0.058x | -38.28% |
| 2018-12-31 | CN¥560.04 Million | CN¥52.75 Million | 0.094x | +2.84% |
| 2017-12-31 | CN¥537.57 Million | CN¥49.24 Million | 0.092x | -76.34% |
| 2016-12-31 | CN¥256.69 Million | CN¥99.35 Million | 0.387x | -5.01% |
| 2015-12-31 | CN¥222.51 Million | CN¥90.66 Million | 0.407x | +16.89% |
| 2014-12-31 | CN¥210.90 Million | CN¥73.52 Million | 0.349x | +191.73% |
| 2013-12-31 | CN¥168.57 Million | CN¥20.14 Million | 0.119x | -80.93% |
| 2012-12-31 | CN¥121.38 Million | CN¥76.07 Million | 0.627x | -- |